查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611209

CRISPR 和 Cas 基因市场规模、份额和趋势分析报告：按产品/服务、应用、最终用途、地区和细分市场预测，2025-2030 年

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Cell Line Engineering), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

CRISPR 和 Cas 基因市场成长和趋势

Grand View Research, Inc.最新报告显示，到2030年，全球CRISPR和Cas基因市场规模预计将达到113.3亿美元，2025年至2030年复合年增长率为16.12%。由于基因组编辑片段的发展，CRISPR-Cas系统在原核诊断和演化分析评估中的使用显着增加。该技术的应用使得轻鬆且低成本地编辑基因成为可能。基因组编辑在生物医学研究方面取得了长足的进步，当前的最尖端科技趋势正在为未来治疗多种遗传和非遗传疾病铺平道路。

CRISPR/Cas9介导的基因和基因组编辑技术的出现促进了更有效的基因标靶方法的开发和实施以及基因编辑鸟类的创造。根据 2021 年 2 月发表在 Frontiers 上的一篇论文，CRISPR/Cas9 已成为家禽业基因编辑的强大且重要的工具。预计多个领域的潜在应用将进一步推动对该技术的需求。 COVID-19 的爆发已将研究人员的注意力转移到利用该技术开发 COVID-19 分子诊断工具。例如，2021 年 3 月，新加坡南洋理工大学的研究人员创建了基于 CRISPR 的 COVID-19 测试，可以在 30 分钟内提供结果。

即使病毒发生变异，此测试也能侦测到该病毒。这将进一步鼓励其他主要企业利用这项技术，进一步促进产业成长。这项技术越来越多地用于医疗和其他应用。随着越来越多的学术机构和生物技术公司寻求为该技术开发新的商业性应用，这些基因编辑技术的专利竞争预计将加剧。此外，透过使用机器学习技术来推进这项技术具有巨大的潜力。例如，2022 年 8 月，Synthego 推出了工程细胞库，这是一项尖端服务，透过排列 CRISPR 编辑的细胞以直接用于我所做的功能筛检实验，从而扩大了 CRISPR 的使用范围。

有望应用于疾病研究。主要企业为基因编辑工作流程的每个步骤提供工具和解决方案。透过整合多种工具、服务和改进的流程，您可以更快、更轻鬆地完成研究实验。此外，主要企业也筹集了大量资金来支持 CRISPR 和 Cas9 基因编辑方法的研究和开发。例如，2021年4月，Vertex Pharmaceuticals与CRISPR Therapeutics合作开发和製造一种基于CRISPR/Cas9的新型基因编辑疗法，名为CTX001，该疗法可能成为输血依赖性β地中海贫血和镰状细胞疾病（SCD）的治疗选择我做到了。 2020 年 1 月，Mammoth Biosciences 筹集了 4,500 万美元，用于开发用于治疗和诊断目的的下一代 CRISPR 产品。这将进一步用于开发该公司的 CRISPR 基因主导诊断产品组合。

CRISPR 和 Cas 基因市场报告亮点

  • 从产品和服务来看，2024年产品细分市场占据产业主导地位，占比最高，达77.39%。
  • 到2024年，生物医药领域将主导该产业。广泛的研究和利用基因组编辑先进技术的研究数量的显着增加正在促进这一领域的成长。
  • 2024年，生技和製药公司占据市场主导地位，占整体收益占有率的49.56%。主要企业正在利用这项技术创建人类疾病的生物模型，并进一步加速新治疗标靶的识别。
  • 北美市场占据主导地位，2024 年收益占有率最高，达 41.36%。这是由于多个製药巨头的存在、研究经费的增加、更多的研究核准以及对新疗法的需求。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 工业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章产品/服务业务分析

  • 产品/服务细分仪表板
  • 全球 CRISPR 和 CAS 基因市场：产品/服务波动分析
  • 2018-2030 年全球 CRISPR 和 CAS 基因市场规模和趋势分析（按产品/服务）
  • 产品
    • 产品市场，2018-2030
    • 试剂套件和试剂
    • 图书馆
    • 设计工具
    • 抗体
    • 其他的
  • 服务
    • 服务市场，2018-2030
    • 细胞株工程
    • gRNA设计与合成
    • 筛检服务
    • 其他的

第五章 应用业务分析

  • 使用细分仪表板
  • 全球CRISPR和CAS基因市场：应用变异分析
  • 2018-2030 年全球 CRISPR 与 CAS 基因市场规模及趋势分析（按应用）
  • 生物医学
    • 生物医药市场，2018-2030
    • 基因组工程
    • 疾病模型研究
    • 功能基因体学
    • 表观遗传学
    • 其他的
  • 农业
    • 农产品市场，2018-2030

第六章 最终用途业务分析

  • 最终用途细分仪表板
  • 全球 CRISPR 和 CAS 基因市场：最终用途变异分析
  • 2018-2030 年全球 CRISPR 和 CAS 基因市场规模和趋势分析（按最终用途）
  • 生物技术和製药公司
    • 生物技术和製药市场，2018-2030
  • 学术/政府研究院
    • 学术与政府研究市场，2018-2030
  • 合约研究组织（CRO）
    • 合约研究组织 (CRO) 市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第七章 区域业务分析

  • 区域仪表板
  • 2018-2030年市场规模、预测与趋势分析
  • 北美洲
    • 北美 CRISPR 和 CAS 基因市场，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲 CRISPR 和 CAS 基因市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区 CRISPR 和 CAS 基因市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲 CRISPR 和 CAS 基因市场，2018-2030 年
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 中东和非洲 CRISPR 和 CAS 基因市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 参与企业
  • 策略规划
  • 2024 年企业市场分析
  • 公司简介/上市公司
    • Thermo Fisher Scientific
    • Illumina
    • Agilent Technologies
    • Synthego
    • Danaher
    • Origene Technologies
    • GenScript
    • Lonza
    • Revvity, Inc.
    • Merck KGaA
Product Code: GVR-1-68038-375-1

CRISPR And Cas Genes Market Growth & Trends:

The global CRISPR and Cas genes market size is expected to reach USD 11.33 billion by 2030, growing at a CAGR of 16.12% from 2025 to 2030, according to a new report by Grand View Research, Inc. The use of CRISPR-Cas systems in diagnostics and the assessment of evolutionary analysis in prokaryotes has significantly increased, owing to the developments in the field of genome editing. The application of this technology enables easy and cost-efficient editing of genes. Genome editing has made a significant advancement in biomedical research, with the present trend of cutting-edge techniques paving the way for the future treatment of different genetic and non-genetic disorders.

The development and implementation of more effective ways for gene targeting and the generation of gene-edited avian species have been facilitated by the availability of the CRISPR/Cas9-mediated gene and genome editing technology. According to an article published on Frontiers in February 2021, CRISPR/Cas9 has become a robust and important tool for gene editing in the poultry industry. Potential applications in several fields would further boost the demand for this technology. The COVID-19 outbreak shifted the researcher's emphasis to the development of COVID-19 molecular diagnostic tools based on this technology. For instance, in March 2021, Nanyang Technological University researchers in Singapore created a COVID-19 test based on CRISPR that provides results in 30 minutes.

Even after the virus has mutated, this test still discovers it. This would further encourage the other key players to leverage this technique, thereby driving the industry's growth. This technology is increasingly being used for several medical and other applications. Competition over patents for such a gene-editing technology is expected to grow, as more academic institutions and biotech companies attempt to develop new commercial applications of this technology. In addition, there is a lot of potential for this technique to advance with the use of machine learning technologies. For instance, in August 2022, Synthego launched engineered cell libraries, a cutting-edge service that expands access to CRISPR by giving arrayed CRISPR-edited cells for use directly in functional screening experiments.

It has potential applications in disease research. Key players offer tools and solutions for each step of the gene editing workflow. Integrating several tools, services, and improved processes makes it possible to complete research experiments rapidly and with little effort. Moreover, key players have raised significant funding to support the R&D of the CRISPR & Cas9 gene-editing approach. For instance, in April 2021, Vertex Pharmaceuticals collaborated with CRISPR Therapeutics to develop and manufacture a new CRISPR/Cas9-based gene editing therapy called CTX001, a potential therapeutic option for transfusion-dependent beta-thalassemia and Sickle Cell Disease (SCD). In January 2020, Mammoth Biosciences raised USD 45 million to develop next-gen CRISPR products for therapeutics & diagnostics purposes. This would further be used to develop the company's CRISPR genes-driven diagnostics portfolio.

CRISPR And Cas Genes Market Report Highlights:

  • By product and services, the product segment dominated the industry in 2024 and accounted for the highest share of 77.39%
  • The biomedical segment dominated the industry in 2024. Extensive research and a significant rise in the number of research studies utilizing the advanced technique for genome editing have contributed to the segment growth
  • The biotechnology and pharmaceutical companies dominated the market in 2024, accounting for 49.56% of overall revenue share. Key players are adopting this technology to produce biological models for human diseases and further accelerate new therapeutic target identification
  • North America dominated the market and accounted for the highest revenue share of 41.36% in 2024 owing to the presence of several pharmaceutical giants, increased research funding, a high number of research approvals, and the need for novel therapeutics

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Need For Novel Therapeutics
      • 3.2.1.2. Rising Demand For Gene Editing
      • 3.2.1.3. Rising Incidence Of Cancer
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Off-Target Effects Of CRISPR Technology
      • 3.2.2.2. High Cost Factor, Intellectual Property Disputes & Ethical Dilemma
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product & Service Business Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global CRISPR And CAS Genes Market: Product & Service Movement Analysis
  • 4.3. Global CRISPR And CAS Genes Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Products Market, 2018 - 2030 (USD Million)
    • 4.4.2. Kits & Reagents
      • 4.4.2.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
      • 4.4.2.2. Cas Proteins & Enzymes
        • 4.4.2.2.1. Cas Proteins & Enzymes Market, 2018 - 2030 (USD Million)
      • 4.4.2.3. Guide RNA
        • 4.4.2.3.1. Guide RNA Market, 2018 - 2030 (USD Million)
      • 4.4.2.4. Others
        • 4.4.2.4.1. Others Market, 2018 - 2030 (USD Million)
    • 4.4.3. Libraries
      • 4.4.3.1. Libraries Market, 2018 - 2030 (USD Million)
    • 4.4.4. Design Tool
      • 4.4.4.1. Design Tool Market, 2018 - 2030 (USD Million)
    • 4.4.5. Antibodies
      • 4.4.5.1. Antibodies Market, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Other Products Market, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market, 2018 - 2030 (USD Million)
    • 4.5.2. Cell Line Engineering
      • 4.5.2.1. Cell Line Engineering Market, 2018 - 2030 (USD Million)
    • 4.5.3. gRNA Design & Synthesis
      • 4.5.3.1. gRNA Design & Synthesis Market, 2018 - 2030 (USD Million)
    • 4.5.4. Screening Services
      • 4.5.4.1. Screening Services Market, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global CRISPR And CAS Genes Market: Application Movement Analysis
  • 5.3. Global CRISPR And CAS Genes Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Biomedical
    • 5.4.1. Biomedical Market, 2018 - 2030 (USD Million)
    • 5.4.2. Genome Engineering
      • 5.4.2.1. Genome Engineering Market, 2018 - 2030 (USD Million)
    • 5.4.3. Disease Model Studies
      • 5.4.3.1. Disease Model Studies Market, 2018 - 2030 (USD Million)
    • 5.4.4. Functional Genomics
      • 5.4.4.1. Functional Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.5. Epigenetics
      • 5.4.5.1. Epigenetics Market, 2018 - 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Other Biomedical Applications Market, 2018 - 2030 (USD Million)
  • 5.5. Agricultural
    • 5.5.1. Agricultural Market, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global CRISPR And CAS Genes Market: End Use Movement Analysis
  • 6.3. Global CRISPR And CAS Genes Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Biotechnology & Pharmaceutical Companies
    • 6.4.1. Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.5. Academic & Government Research Institutes
    • 6.5.1. Academic & Government Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.6. Contract Research Organizations (CROs)
    • 6.6.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. CRISPR And CAS Genes Market, 2018 - 2030 (USD MILLION)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Germany CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. UK CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. South Korea CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Australia CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Thailand CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product/Service Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Illumina
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product/Service Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Agilent Technologies
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product/Service Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Synthego
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product/Service Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Danaher
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product/Service Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Origene Technologies
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product/Service Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. GenScript
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product/Service Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Lonza
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product/Service Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Revvity, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product/Service Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Merck KGaA
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product/Service Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 3 Global CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global CRISPR and Cas genes market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 8 North America CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 11 U.S. CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 14 Canada CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 17 Mexico CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 21 Europe CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 24 Germany CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 27 UK CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 30 France CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 31 France CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 33 Italy CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 36 Spain CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 39 Denmark CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 42 Sweden CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 45 Norway CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 52 China CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 53 China CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 55 Japan CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 58 India CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 59 India CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 61 Australia CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Thailand CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 64 Thailand CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 65 Thailand CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 66 South Korea CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 67 South Korea CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 68 South Korea CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 71 Latin America CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 74 Brazil CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 77 Argentina CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East and Africa CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East and Africa CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 81 Middle East and Africa CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 82 Middle East and Africa CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 84 South Africa CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 90 UAE CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
  • Table 93 Kuwait CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 CRISPR and Cas genes market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global CRISPR and Cas genes market: Product & service movement analysis
  • Fig. 15 Global CRISPR and Cas genes market, for product, 2018 - 2030 (USD Million)
  • Fig. 16 Global CRISPR and Cas genes market, for kits & enzymes, 2018 - 2030 (USD Million)
  • Fig. 17 Global CRISPR and Cas genes market, for Cas proteins & enzymes, 2018 - 2030 (USD Million)
  • Fig. 18 Global CRISPR and Cas genes market, for guide RNA, 2018 - 2030 (USD Million)
  • Fig. 19 Global CRISPR and Cas genes market, for others, 2018 - 2030 (USD Million)
  • Fig. 20 Global CRISPR and Cas genes market, for libraries, 2018 - 2030 (USD Million)
  • Fig. 21 Global CRISPR and Cas genes market, for design tool, 2018 - 2030 (USD Million)
  • Fig. 22 Global CRISPR and Cas genes market, for antibodies , 2018 - 2030 (USD Million)
  • Fig. 23 Global CRISPR and Cas genes market, for other products, 2018 - 2030 (USD Million)
  • Fig. 24 Global CRISPR and Cas genes market, for service, 2018 - 2030 (USD Million)
  • Fig. 25 Global CRISPR and Cas genes market, for cell line engineering , 2018 - 2030 (USD Million)
  • Fig. 26 Global CRISPR and Cas genes market, for gRNA design & synthesis, 2018 - 2030 (USD Million)
  • Fig. 27 Global CRISPR and Cas genes market, for screening services, 2018 - 2030 (USD Million)
  • Fig. 28 Global CRISPR and Cas genes market, for other services, 2018 - 2030 (USD Million)
  • Fig. 29 Global CRISPR and Cas genes market: Application movement analysis
  • Fig. 30 Global CRISPR and Cas genes market, for biomedical , 2018 - 2030 (USD Million)
  • Fig. 31 Global CRISPR and Cas genes market, for genome engineering, 2018 - 2030 (USD Million)
  • Fig. 32 Global CRISPR and Cas genes market, for disease model studies, 2018 - 2030 (USD Million)
  • Fig. 33 Global CRISPR and Cas genes market, for functional genomics, 2018 - 2030 (USD Million)
  • Fig. 34 Global CRISPR and Cas genes market, for epigenetics, 2018 - 2030 (USD Million)
  • Fig. 35 Global CRISPR and Cas genes market, for other biomedical applications, 2018 - 2030 (USD Million)
  • Fig. 36 Global CRISPR and Cas genes market, for agricultural , 2018 - 2030 (USD Million)
  • Fig. 37 Global CRISPR and Cas genes market: End Use movement analysis
  • Fig. 38 Global CRISPR and Cas genes market, for biotechnology & pharmaceutical companies, 2018 - 2030 (USD Million)
  • Fig. 39 Global CRISPR and Cas genes market, for academic & government research institutes, 2018 - 2030 (USD Million)
  • Fig. 40 Global CRISPR and Cas genes market, for Contract Research Organizations (CROs), 2018 - 2030 (USD Million)
  • Fig. 41 Global CRISPR and Cas genes market, for other end use, 2018 - 2030 (USD Million)
  • Fig. 42 Regional outlook, 2024 & 2030
  • Fig. 43 North America CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 45 Canada CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 47 Europe CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 48 Germany CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 49 UK CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 50 France CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 51 Italy CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 52 Spain CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 55 Norway CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 57 Japan CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 58 China CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 59 India CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 60 Australia CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 66 MEA CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 69 UAE CRISPR and Cas genes market, 2018 - 2030 (USD Million)
  • Fig. 70 Kuwait CRISPR and Cas genes market, 2018 - 2030 (USD Million)